Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020

Key Points

• Cardiovascular-kidney-metabolic syndrome stages demonstrate measurable prevalence across US adults, marking critical shifts in systemic disease progression.
• Cross-sectional study evaluates the temporal evolution of cardiovascular-kidney-metabolic syndrome stages from 2011 through 2020 in national survey data.
• Characterizing cardiovascular-kidney-metabolic syndrome distribution highlights population health trends, supporting earlier multi-organ interventions.